Bottom line
How much do FSHCX and GGHCX overlap?
18% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 45.6% of FSHCX's assets and 15.0% of GGHCX's. They are substantially different portfolios, so owning both adds real diversification.
GGHCX holds far more positions (82 vs 40), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FSHCX and GGHCX have in common
| Holding | % of FSHCX | % of GGHCX | Overlap |
|---|---|---|---|
| Unitedhealth Group Inc | 24.53% | 6.17% | 6.17% |
| Cvs Health Corp | 12.98% | 2.52% | 2.52% |
| Brightspring Health Services Inc | 5.28% | 2.20% | 2.20% |
| Cardinal Health Inc | 1.42% | 2.10% | 1.42% |
| Guardant Health Inc | 1.39% | 2.04% | 1.39% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FSHCX
- Elevance Health Inc — 10.59%
- Fidelity Revere Street Trust — 7.41%
- Mckesson Corp — 4.82%
- Cencora Inc — 4.64%
- Tenet Healthcare Corp — 3.08%
- Humana Inc — 2.63%
- Alignment Healthcare Inc — 2.58%
- Privia Health Group Inc — 2.07%
- Davita Inc — 2.04%
- Fidelity Revere Street Trust — 1.95%
- Pediatrix Medical Group Inc — 1.86%
- Astrana Health Inc — 1.85%
- Encompass Health Corp — 1.80%
- Surgery Partners Inc — 1.75%
- Lifestance Health Group Inc — 1.69%
Only in GGHCX
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- Welltower Inc. — 2.34%
- Royalty Pharma PLC — 2.13%
- Vertex Pharmaceuticals Inc. — 2.01%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Edwards Lifesciences Corp. — 1.56%
- Invesco Treasury Portfolio — 1.56%
- Thermo Fisher Scientific Inc. — 1.55%
Asset mix
| Asset type | FSHCX | GGHCX |
|---|---|---|
| Stocks | 92.0% | 97.5% |
| Cash & short-term funds | 9.4% | 8.8% |
| Preferred stock | 0.6% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Country mix
| Country | FSHCX | GGHCX |
|---|---|---|
| US | 102.0% | 93.5% |
| NL | — | 3.4% |
| GB | — | 3.1% |
| CH | — | 2.7% |
| BE | — | 1.2% |
| DK | — | 1.1% |
| IE | — | 0.6% |
| IL | — | 0.4% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do FSHCX and GGHCX overlap?
What stocks do FSHCX and GGHCX have in common?
Should I own both FSHCX and GGHCX?
Which holds more stocks, FSHCX or GGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.